MacroGenics-Logo-(transparent-background).png
MacroGenics Announces Date of Second Quarter 2021 Financial Results Conference Call
July 22, 2021 16:05 ET | MacroGenics, Inc.
ROCKVILLE, MD, July 22, 2021 (GLOBE NEWSWIRE) --   MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based...
MacroGenics-Logo-(transparent-background).png
MacroGenics and Zai Lab Enter Into Broad Strategic Collaboration to Develop and Commercialize Preclinical Bispecific Antibodies in Oncology
June 16, 2021 07:30 ET | MacroGenics, Inc.
Zai Lab granted combination of regional Asian and global rights for up to four CD3- or CD47-based bispecific moleculesMacroGenics provides rights to Zai Lab for its DART® and TRIDENT® multi-specific...
MacroGenics-Logo-(transparent-background).png
MacroGenics Announces Preliminary Clinical Results from Phase 1 Study of MGC018 to be Presented at ASCO Annual Meeting
May 19, 2021 17:05 ET | MacroGenics, Inc.
Dose escalation: anti-tumor activity observed in melanoma (including one confirmed partial response) and in mCRPC patientsCohort expansion in mCRPC: 11/22 (50%) patients have ≥ 50% PSA reduction;...
MacroGenics-Logo-(transparent-background).png
MacroGenics to Participate in Upcoming Investor Conference
May 19, 2021 07:00 ET | MacroGenics, Inc.
ROCKVILLE, MD, May 19, 2021 (GLOBE NEWSWIRE) --   MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based...
Zenas-logo-rgb.png
Zenas BioPharma Announces New Executive Leadership Appointments
May 03, 2021 05:00 ET | Zenas BioPharma
Hua Mu, MD, Ph.D. appointed President, CEO and Acting CMO Joe Farmer appointed CBO HONG KONG and BOSTON, May 03, 2021 (GLOBE NEWSWIRE) -- Zenas BioPharma (“Zenas”), a cross-border (China-USA...
Zenas-logo-rgb.png
Zenas BioPharma宣布任命新任高管
May 03, 2021 05:00 ET | Zenas BioPharma
牟骅博士被任命为总裁、首席执行官兼代理首席医疗官 Joe Farmer被任命为首席商务官 香港和波士顿, May 03, 2021 (GLOBE NEWSWIRE) -- 致力于开发和提供免疫疗法的跨国(中国-美国)生物制药公司Zenas BioPharma(以下称“Zenas”)今天宣布,任命牟骅博士为总裁兼首席执行官及代理首席医疗官,任命Joe Farmer为首席商务和行政官。 ...
Zenas-logo-rgb.png
Zenas BioPharma 宣佈任命新的執行領導
May 03, 2021 05:00 ET | Zenas BioPharma
Hua Mu MD, Ph.D. 獲任命為總裁、行政總裁兼代理醫務總監 Joe Farmer 獲任命出任業務總監 香港和波士頓, May 03, 2021 (GLOBE NEWSWIRE) -- Zenas BioPharma(「Zenas」)是一家致力開發和交付免疫治療的跨境(中美兩國)生物製藥公司,今天宣佈任命 Hua Mu, MD, Ph.D. 擔任總裁、行政總裁兼代理醫務總監,而...
Zenas-logo-rgb.png
Zenas BioPharma annonce de nouvelles nominations dans son équipe de haute direction
May 03, 2021 05:00 ET | Zenas BioPharma
Hua Mu, MD, Ph.D. nommé président-directeur général et directeur médical par intérim Joe Farmer nommé directeur commercial HONG KONG et BOSTON, 03 mai 2021 (GLOBE NEWSWIRE) -- Zenas BioPharma...
Zenas-logo-rgb.png
Zenas BioPharma gibt Ernennungen neuer Führungskräfte bekannt
May 03, 2021 05:00 ET | Zenas BioPharma
Hua Mu, MD, Ph.D. zum President, CEO und Acting CMO ernannt Joe Farmer zum CBO ernannt HONGKONG und BOSTON, May 03, 2021 (GLOBE NEWSWIRE) -- Zenas BioPharma („Zenas“), ein internationales (in...
Zenas-logo-rgb.png
Zenas BioPharma Mengumumkan Penunjukan Kepemimpinan Eksekutif Baru
May 03, 2021 05:00 ET | Zenas BioPharma
Hua Mu, MD, Ph.D. Presiden, CEO terpilih, dan pelaksana tugas CMO Joe Farmer CBO terpilih HONG KONG dan BOSTON, May 03, 2021 (GLOBE NEWSWIRE) -- Zenas BioPharma (“Zenas”), perusahaan biofarmasi...